Indeed, peripheral blood analyses in pancreatic cancer patients reveal diminished concentrations of Th17 cells and IL-17 compared to healthy counterparts [50], with further declines in more advanced stages of the disease [50]. Here, IL17A is linked to pancreatic neoplasm.